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dDepartment of Surgery, St Joseph’s Healthcare and Faculty of Health Sciences, McMaster University, Hamilton, Ontario, CanadaAbstractPurpose: The aim of this study was to evaluate the accuracy of multidetector computed tomography (MDCT) in the detection of parathyroid
adenoma and hyperplasia in the setting of primary hyperparathyroidism.
Methods: Records of 48 patients with biochemically confirmed primary hyperparathyroidism, who underwent preoperative imaging with 16-
or 64-slice contrast-enhanced MDCT and subsequent successful parathyroidectomy over a 3-year period, were reviewed. Two radiologists,
blinded to the operative and histologic findings, independently evaluated multiplanar computed tomographic images for all patients.
Results: On pathologic examination, 63 abnormal glands were confirmed in 41 female and 7 male patients (mean age, 63 years). Of the 63
abnormal glands, 40 were adenomatous and 23 were hyperplastic. MDCT demonstrated an 88% (95% confidence interval [CI], 77%e99%)
positive predictive value for localizing abnormal hyperfunctioning parathyroid glands. The sensitivity of MDCT in detecting single-gland
disease was 80% (95% CI, 68%e92%); whereas the specificity for ruling out hyperfunctioning parathyroid tissue, either adenomatous or
hyperplastic, was 75% (95% CI, 51%e99%). The sensitivity for exclusively localizing parathyroid hyperplasia was 17% (95% CI, 2%e
33%). The parathyroid adenomas were substantially larger and heavier than their hyperplastic counterparts, with an average weight of 1.51 g
(range, 0.08e6.00 g) and 0.42 g (range, 0.02e2.0 g) for adenoma and hyperplasia, respectively.
Conclusions: Contrast-enhanced MDCT demonstrated an 88% positive predictive value for localizing adenomatous and hyperplastic
parathyroid glands. The poor sensitivity for detection of multigland disease was likely a result of the smaller size and weight of the abnormal
hyperplastic glands.ResumeObjectif : Cette etude visait a evaluer la performance de la tomographie par ordinateur (CT Scanner) a detecteurs multiples dans la detection
de l’adenome parathyro€ıdien et de l’hyperplasie menant a l’hyperparathyro€ıdie primaire.
Methodes : On a examine sur une periode de trois ans les dossiers de 48 patients chez qui une hyperparathyro€ıdie primaire a ete confirmee a
la suite d’une analyse biochimique et qui ont subi un examen par CT Scanner a 16 ou 64 rangees de detecteurs avec injection de contraste
dans le suivi d’une parathyro€ıdectomie reussie. Deux radiologistes ignorant les resultats operatoires et histologiques ont evalue
independamment les images multiplanaires de tous les patients.
Resultats : A l’examen pathologique, 63 glandes anormales ont ete decelees chez 41 femmes et 7 hommes (d’un a^ge moyen de 63 ans). Sur
ces 63 glandes anormales, 40 etaient adenomateuses et 23, hyperplasiques. On a constate que le CT Scanner a detecteurs multiples avait une
valeur predictive positive de 88 % (intervalle de confiance [IC] de 95 %, de 77 a 99 %) pour la localisation de glandes parathyro€ıdes
hyperactives, donc anormales. Le CT Scanner a detecteurs multiples a permis de deceler l’affection d’une seule glande a 80 % (IC de 95 %,
de 68 a 92 %). La specificite diagnostique permettant d’ecarter l’hypothese d’un tissu parathyro€ıdien hyperactif, qu’il soit adenomateux ou
hyperplasique, etait quant a elle de 75 % (IC de 95 %, de 51 a 99 %). L’examen a permis de deceler une hyperplasie des glandes* Address for correspondence: Dorota D. Linda, MD, St Joseph’s Healthcare Hamilton, Faculty of Health Sciences, McMaster University, 50 Charlton
Avenue East, Hamilton, Ontario L8N 4A6, Canada.
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101MDCT for detection of parathyroid disease / Canadian Association of Radiologists Journal 63 (2012) 100e108parathyro€ıdes seule dans 17 % des cas (IC de 95 %, de 2 a 33 %). La taille et le poids des adenomes parathyro€ıdiens etaient nettement
superieurs a ceux des glandes hyperplasiques : le poids moyen des glandes adenomateuses etant de 1,51 g (fourchette de 0,08 a 6 g) et celui
des glandes hyperplasiques, de 0,42 g (fourchette de 0,02 a 2,0 g).
Conclusions : On constate que le CT Scanner a detecteurs multiples a une valeur predictive positive de 88 % pour la detection des glandes
parathyro€ıdes adenomateuses et hyperplasiques. La faible capacite de l’examen a detecter les affections touchant plusieurs glandes decoule
probablement de la petite taille et du faible poids des glandes hyperplasiques anormales.
 2012 Canadian Association of Radiologists. All rights reserved.
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99mPrimary hyperparathyroidism is a disorder characterized
by an excessive secretion of parathyroid hormone by one or
more hyperfunctioning parathyroid glands, diagnosed on the
biochemical basis of hypercalcemia with associated high
parathormone levels. By far, the most common cause of
primary hyperparathyroidism is a solitary parathyroid
adenoma (85%), followed by hyperplasia (10%), multiple
adenomas (4%), and, rarely, parathyroid carcinoma [1].
Over the past decade, the curative surgical approach to
parathyroid disease has shifted from the traditional bilateral
4-gland exploration to more minimally invasive techniques,
including unilateral, open, video-assisted, and videoscopic
parathyroidectomies. These newer procedures substantially
improve operative time, postoperative recovery, and cosmetic
results [2e4]. As a result, accurate preoperative localization
has become unquestionably crucial.
Ultrasound (US) and nuclear medicine (NM) have tradi-
tionally been used to image the parathyroid glands. The
accuracies of these modalities for detecting hyperfunctioning
parathyroid tissue vary widely, with reported sensitivities of
16%e85% for US [1,5e7] and 44%e95% for NM [2,3,7].
Although US is a low-cost, widely available modality, it is
highly operator dependent and has limited value in diag-
nosing ectopic hyperfunctioning glands. NM techniques,
such as technetium 99m (99mTc) sestamibi provide functional
information about aberrant parathyroid glands; however,
both planar sestamibi and single photon emission computed
tomography (SPECT) imaging demonstrate very little
anatomical definition. Moreover, as the techniques of sesta-
mibi scanning vary among institutions, the quality fluctuates
considerably.
With respect to the essential preoperative localization
required for minimally invasive surgery, CT offers several
advantages over the more traditional modalities. MDCT is
widely available, reproducible, and relatively low cost. It
inherently provides high-level anatomical detail and provides
visualization of areas not easily accessible by US, such as the
deeper paraesophageal region and mediastinum [1,5].
Furthermore, MDCT enables rapid exploration of the entire
neck and upper mediastinum, defining the relationships
between the enlarged parathyroid glands, thyroid, vascular
structures, and lymph nodes.
CT is emerging as a promising imaging modality in the
workup of primary hyperparathyroidism, especially in
combination with other modalities [6,8,9]. Our institutional
preoperative imaging algorithm uses 99mTc-sestamibi singlephoton emission computed tomography imaging, Tc-
pertechnetate subtraction imaging, and MDCT, which has
become the predominant preoperative imaging modality,
particularly preferred by our surgery colleagues.
There exists a relative paucity of investigations that
examined the use of contrast-enhanced MDCT for the
localization of both parathyroid adenoma and hyperplasia.
The purpose of the current study was to determine the
accuracy of contrast-enhanced MDCT for localizing hyper-
functioning parathyroid disease in the setting of primary
hyperparathyroidism.
Material and MethodsSubjectsResearch ethics board approval was obtained for this
retrospective case-controlled study. To identify individuals in
this series, the institutional radiology report archives at
a tertiary referral centre were electronically searched through
a time period of 3 years. Reports from multiple imaging
modalities were searched, including CT, NM, and US, by
using the terms ‘‘hyperparathyroidism’’ and ‘‘parathyroid.’’
To identify additional subjects, surgical databases of the
involved surgeons were examined. The combined queries
produced an extensive list of patients. Patients were selected
on the basis of a biochemical diagnosis of primary
hyperparathyroidism and preoperative imaging with 16- or
64-slice contrast-enhanced CT before undergoing successful
parathyroidectomy. Patients investigated for persistent or
recurrent disease were included in the study. Forty-eight
patients met inclusion criteria. One patient underwent 2 CT
investigations for persistent hyperparathyroidism. Preopera-
tive NM investigations were ordered at our institution or at
an outside centre for 47 patients.Imaging and ProceduresForty-nine CTs were completed at our institution. Twelve
of the 49 CTs (24%) were completed on a 16-slice scanner
(Lightspeed Pro 16; General Electric, Madison, WI), whereas
37 studies (76%) were done on a 64-slice scanner (Light-
speed VCT; General Electric). The scan coverage comprised
a volume from the angle of the mandible to the level of the
carina. The field of view was 25 cm. The kV and rotation
time were 120 and 0.6, respectively, with automatic exposure
Table 1
Classification system introduced by Rogers et al [10]
Gland type Location
A Superior glands in proximity to the posterior surface of
the thyroid
B Superior glands that have fallen posteriorly into the
tracheoesophageal groove, having little or no contact
between the gland and posterior surface of the thyroid,
and in the plane of the superior pole
C Superior glands that have fallen posteriorly into the
tracheoesophageal groove, having little or no contact
between the gland and posterior surface of the thyroid, and
at the level of or below the inferior pole of the thyroid
D Glands lying in the interpolar region, near the junction of the
recurrent laryngeal nerve and the inferior thyroid artery
E Inferior glands near the inferior pole of the thyroid, lying
anterior to the trachea
F Inferior glands that have descended into the thyrothymic
ligament or superior thymus
G Intrathyroidal glands
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(Visipaque; GE Amersham, Princeton, NJ) was administered
at a rate of 3.5 mL/s. Arterial-phase imaging was completed
with a postinjection delay of 35 seconds. The helical volume
raw data were acquired at a slice thickness of 0.625 mm.
The majority of the axial CT images (84%) were viewed as
2.5-mm cuts. Five studies (10%) used 3.75-mm collimation,
whereas a single study (2%) used a slice thickness of 5 mm.
Two examinations (4%) were viewed at 1.5-mm cuts. Three-
millimetre sagittal and coronal reformatted images were
obtained and routinely sent to the Picture Archiving and
Communication System (PACS).
All 48 patients subsequently underwent operative explo-
ration. A head and neck surgeon with a special interest in
parathyroid disease performed the majority of the para-
thyroidectomies (94%). Another head and neck surgeon
completed the remaining 3 surgeries (6%).Data Collection, Definitions, and CriteriaFigure 1. Schematic for categorization of the location of parathyroid glands.
Adapted from Rogers et al [10]. This figure is available in colour online at
http://carjonline.org/.All 49 CTs were retrospectively reviewed on 2 separate
days by 2 radiologists, one with particular experience in
head and neck imaging. The radiologists were blinded to
patient data, including name, hospital identification
number, date of birth, and imaging date. In addition, the
operative findings and histologic results were concealed, as
were the results of other imaging studies (ie, NM scans).
Data sheets were completed at the time of CT reading to
include information about the quality of the CT contrast
enhancement and the size, location, and morphology of the
identified abnormal parathyroid gland(s), if any, were
detected. Glands in a predictable location on the basis of
embryology that demonstrated arterial hyperenhancement
were identified as abnormal. In addition to describing the
location of the abnormal glands during the CT reading,
parathyroid glands were classified type A through G
according to the parathyroid classification system intro-
duced by Rogers et al [10], based on the most commonly
encountered locations of abnormal parathyroid glands
(Table 1 and Figure 1).
In the event of disagreement between the 2 radiologists,
a consensus reading was implemented. Because it was not
the focus of our study, correlation between our retrospective
review and the original written radiology report was not
undertaken. The operative reports from the succeeding
surgeries were studied, and the location of the uncovered
abnormal parathyroid gland was noted and compared with
the position described by CT. In cases in which the operative
information was nebulous, there was discussion with the
involved surgeon to ascertain that the abnormal gland iden-
tified on CT was in fact the diseased gland discovered at
surgery. This surgical location formed the first reference
standard. The associated pathology reports were reviewed,
and the histologic diagnosis was used as the second and final
reference standard. At pathology, the majority of the
abnormal parathyroid glands were measured and weighed.Statistical analysis for the localization of abnormal
parathyroid glands was performed on a per-gland basis. A
true positive (TP) result was assigned to the accurate
prediction of a histologically confirmed abnormal para-
thyroid gland discovered in the same location during
surgical exploration (Figures 2 and 3). If multiple glands
were pronounced abnormal during the CT review and the
same position of those glands was ascertained at surgery,
Figure 2. Contrast-enhanced axial (A) and coronal (B) multidetector computed tomographic images, demonstrating an enlarged left inferior parathyroid gland
(arrow), which was discovered during surgery in this precise location and proven by histologic examination to be an adenoma. This constituted a true-positive
result. This figure is available in colour online at http://carjonline.org/.
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glands were identified on CT and no abnormal glands were
discovered during surgery, then a true negative (TN) result
was registered. A prediction of no parathyroid abnormality
on CT with the discovery of abnormal glands at surgery
constituted a false negative (FN) (Figure 4). A false posi-
tive (FP) result was the product of predicting an abnormal
gland in a particular location, with the surgicalFigure 3. An enlarged, bilobed right superior parathyroid gland (arrow) is ide
computed tomography images. Cystic change is evident. The gland was found dur
positive. This figure is available in colour online at http://carjonline.org/.discovery of a normal parathyroid gland at that particular
site (Figure 5).
The term multigland disease (MGD) refers to patients
who had resection of more than one histologically confirmed
hypercellular parathyroid gland (either multiple adenomas or
hyperplasia) during one or multiple operations, regardless of
the time interval between operations. NM results were
obtained for 47 of the 48 patients.ntified on these axial (A) and sagittal (B) contrast-enhanced multidetector
ing surgery, and histology revealed an adenoma. This result was tallied as true
Figure 4. Contrast-enhanced axial (A) and coronal (B) multidetector computed tomography images, demonstrating multinodular goiter with evidence of prior
thyroid surgery (white arrow). A parathyroid adenoma could not be differentiated from thyroid nodules by either reader; however, surgical exploration revealed
a right superior adenoma abutting the esophagus (seen in retrospect, depicted by the red arrow). This was registered as a false-negative result. This figure is
available in colour online at http://carjonline.org/.
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zation were calculated and analysed in relation to our 2
reference standards, the position of the discovered abnor-
mality at surgery and by histologic diagnosis. Pathology
was used as the final and ultimate reference standard.Figure 5. Contrast-enhanced axial (A) and coronal (B) computed tomography ima
to the left common carotid artery. During surgery, this lesion was found within
adenoma. As such, a true-positive result was recorded. Both readers predicted ano
was not proven at the time of surgery. This second lesion constituted a false-posBecause individual glands and not individual patients
were analysed, the data were clustered. Thus, a clustered
analysis was used for sensitivity, specificity, and positive and
negative predictive values; 95% confidence intervals (CI)
were computed. The interobserver agreement between both
radiologists with respect to the CT analysis was calculated by
using the Cohen kappa (k) statistics.ges, revealing an enlarged left inferior parathyroid gland (red arrow) posterior
the carotid sheath, and histology subsequently proved it to be a parathyroid
ther hypervascular lesion to be a parathyroid adenoma (white arrow), but this
itive result. This figure is available in colour online at http://carjonline.org/.
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the third and fourth branchial pouches, develop at 6 weeks of
fetal life. Although most individuals have 4 parathyroid
glands, the number ranges from 2e6. The superior para-
thyroid glands are relatively constant in position because
they are closely related to the thyroid, with minimal caudal
migration. Their most common locations in decreasing order
of frequency are the following: posterior to the middle third
of the thyroid gland at the cricothyroid junction, behind the
upper pole of the thyroid gland, and retropharyngeal or ret-
roesophageal. The inferior parathyroid glands, however, are
more variable in position because their caudal migration
spans a greater distance. Their most common locations in
decreasing order of frequency are the following: behind the
lower pole of the thyroid, within a region 1 cm below the
lower pole of the thyroid, and unpredictably along the thy-
rothymic tract, from the mandibular angle to the lower
mediastinum [5]. Intrathyroidal glands are rare. The dimen-
sions of a normal parathyroid gland are 5  3  1 mm, with
a weight of 30e40 mg [1].
Parathyroid adenomas in the familiar locations immedi-
ately adjacent to the thyroid can be challenging to discrim-
inate from the thyroid gland itself. Conversely, by virtue of
their location, ectopic adenomas are usually clearly identi-
fiable on CT, but it is these unfamiliar locations that pose
a challenge for detection [11]. Hyperplastic and adenoma-
tous parathyroid glands demonstrate arterial hyperenhance-
ment. This feature allows differentiation of diseased
parathyroid glands from a common mimicker, lymph nodes,
which do not exhibit hyperenchancement and are most
commonly isoenhancing relative to adjacent muscle. Careful
tracing of structures that reveal vascular-type enhancement is
essential to exclude blood vessel mimickers [11].
Results
Table 2
Patient characteristicsSubjects
Sex, no. (%)
Women 41 (85)
Men 7 (15)
Age of the patients, years (range) 63 (28-84)
Previous neck surgery, no. patients (%)
Documented 20 (42)
Not documented 28 (58)
Mean (range [reference range]) preoperative
parathyroid hormone levels, pmol/L
38 patients 13.4 (3.0-63.0 [1.6-6.9])
6 patients 121.8 (50-291 [8-50])
4 patients Not available from
institutional laboratory
records
Mean (range [reference range]) preoperative
calcium levels, mmol/L
44 patients: recorded ionized calcium 1.51 (1.32-2.69 [1.18-1.32])
3 patients: recorded nonionized calcium 3.20 (2.76-3.44 [2.15-2.55])
1 patient Not available from
institutional laboratory
recordsForty-eight patients met inclusion criteria, with a total of
49 cases. Forty-one patients were women (85%) and 7
patients were men (15%) (mean age, 63 years; range, 28-84
years). Twenty patients (42%) had a history of previous neck
surgery, including hemithyroidectomy and neck exploration.
Of these 20 patients, 15 (75%) had prior neck explorations
for primary hyperparathyroidism. The remaining 28 patients
(58%) had no documented history of prior surgical
intervention.
Preoperative parathyroid hormone levels were recorded in
both pmol/L and pg/mL. The mean preoperative parathyroid
hormone level was 13.4 pmol/L (reference range,
1.6-6.9 pmol/L) (38 patients) and 121.8 pg/mL (reference
range, 8e50 pg/mL) (6 patients), with a range of 3.0e63.0
pmol/L and 50-291 pg/mL, respectively. Preoperative ionized
and nonionized calcium levels were recorded in mmol/L. The
mean preoperative ionized calcium level was 1.51 mmol/L(reference range, 1.18e1.32 mmol/L) (44 patients) and
nonionized calcium was 3.20 mmol/L (reference range,
2.15e2.55 mmol/L) (3 patients), with a range of 1.32e
2.69 mmol/L and 2.76e3.44 mmol/L, respectively. The
reference range for each biochemical parameter was obtained
from standardized institutional laboratory values. Patient
characteristics are summarized in Table 2. In the 47 patients
who underwent NM testing, 25 studies (53%) revealed no
localization of the offending parathyroid gland(s).Imaging DataPreoperative contrast-enhanced MDCT localization was
completed in all 48 patients, and, of the 49 studies, 50
abnormal parathyroid glands were predicted. Seventy-nine
parathyroid glands were excised or sampled during surgery.
Of these, 63 parathyroid glands were pathologically proven
to be abnormal, either hyperplastic or adenomatous. Of the
48 patients, 40 patients had solitary parathyroid adenomas,
whereas 8 patients had multiple lesions, which accounted for
the 23 hyperplastic glands. Of these 8 patients, 3 patients had
2-gland disease, 3 patients had 3-gland disease, and 2
patients had 4-gland disease.
The imaging data are summarized in Table 3. MDCT
evaluation for the localization of parathyroid adenoma and
hyperplasia yielded 36 TP, 15 TN, 5 FP, and 27 FN results. In
5 cases, review of the CT predicted no abnormality, either TP
or FP. Exclusive evaluation for a solitary parathyroid
adenoma revealed 32 TP and 8 FN results, whereas the
outcome in hyperplastic gland assessment was 4 TP and 19
FN results. Therefore, the sensitivity of MDCT in localizing
single-gland disease (parathyroid adenoma) was 80% (95%
CI, 68%e92%); whereas the specificity for ruling out a hy-
perfunctioning parathyroid gland (either an adenoma or
hyperplasia) was 75% (95% CI, 51%e99%). The sensitivity
Table 3
Imaging data
MDCT localization TP TN FP FN Sensitivity, % Specificity, % PPV, % NPV, %
Parathyroid adenoma 32 8 80
Parathyroid hyperplasia (MGD) 4 19 17
All glands 36 15 5 27 57 75 88 36
FN ¼ false negative; FP ¼ false positive; MDCT ¼ multidetector computed tomography; MGD ¼ multigland disease; NPV ¼ negative predictive value;
PPV ¼ positive predictive value; TN ¼ true negative; TP ¼ true positive.
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(95% CI, 44%,-71%). The sensitivity for exclusively diag-
nosing parathyroid hyperplasia was 17% (95% CI, 2%e
33%). The radiologic diagnosis of an abnormal parathyroid
gland, either adenoma or hyperplasia, yielded a positive
predictive value of 88% (95% CI, 77%e99%) and a negative
predictive value of 36% (95% CI, 17%e54%).
Gland types in correctly localized disease (ie, TP results)
are summarized in Table 4, according to the classification
proposed by Rogers et al [10]. The most frequently occurring
glands that were correctly localized, in decreasing order,
were types C, E, D, B, F, and A. No type G (intrathyroidal)
glands were correctly identified.
Of the 63 histologically proven abnormal glands, 37
glands (25 adenomas and 12 hyperplastic glands) were
weighed after excision. The parathyroid adenomas were
substantially larger and thus heavier than their hyperplastic
counterparts, with an average weight of 1.51 g (range, 0.08-
6.00 g). The average weight of a hyperplastic gland,
however, was 0.42 g (range, 0.02e2.00 g). Thus, the average
weight of a hyperplastic gland was less than half a gram, and
more than 90% of the glands weighed less than 1 g.
Furthermore, the average weight of a missed hyperplastic
gland on MDCT (FN result) was 0.2 g, with all of the missed
hyperplastic glands weighing less than 0.8 g (Table 5). A
Cohen k value of 0.42 reflected a moderate strength of
interobserver agreement [12] between the 2 radiologist
readers.
Discussion
In our series, contrast-enhanced MDCT demonstrated an
88% positive predictive value for localizing abnormal
hyperfunctioning parathyroid glands. The specificity for
ruling out hyperfunctioning parathyroid tissue, either
adenomatous or hyperplastic, was 75%. The sensitivities forTable 4
Gland types in patients with both solitary adenoma and multigland disease
Gland typea No. of glands (%)
A 1 (3)
B 5 (14)
C 11 (31)
D 7 (19)
E 8 (22)
F 4 (11)
G 0 (0)
aAs defined in Table 1.exclusively diagnosing parathyroid adenoma and hyperplasia
were 80% and 17%, respectively.
Over the past decade, with the escalating use of minimally
invasive surgical procedures, the removal of aberrant para-
thyroid tissue has essentially become an image-guided
endeavor, and close preoperative collaboration between the
radiologist and the surgeon is crucial for the success of such
surgical techniques. Contrast-enhanced MDCT displays
precise anatomy and defines relationships between important
structures in the neck. It gains access to US-elusive areas
such as the deeper paraesophageal region and mediastinum
and has the capability of localizing ectopic parathyroid
glands [5]. Such exact 3-dimensional localization carries
implications for surgical approach and hospital logistics,
such as operating room time [4]. At our institution, a CT-
localized parathyroid adenoma is booked as a 20-minute
case, whereas indeterminate MDCT results or evidence of
MGD requires a much longer, 1 hour, operative booking in
anticipation of a traditional 4-gland bilateral neck explora-
tion. This series demonstrates that contrast-enhanced MDCT
is a good preoperative modality in localizing parathyroid
adenomas, the etiology responsible for the overwhelming
majority of primary hyperparathyroidism cases.
Few studies have evaluated CT as a tool for detecting para-
thyroid disease, particularly the use of MDCT [8,10,13], and
even fewer investigationshave assessed localization, rather than
lateralization, of abnormal parathyroid glands [4,10,13,14]. In
the literature, the sensitivity of thin-section, contrast-enhanced
CT ranges from 46%e88% [3e5,7e10,13,15].
The results of this series are in concert with the findings
reported in the literature with respect to localization of
parathyroid adenomas. Harari et al [4] report a sensitivity of
66% for localization of diseased glands, with a higher sensi-
tivity, of 85%, for correct lateralization. Zald et al [14]
report a sensitivity of 52% and 75% for localization of
disease for 2 distinct interpreters. In that study, the sensitivityTable 5
Weights of parathyroid adenomas and hyperplastic glands
Weights of 37 weighed diseased glands both correctly
localized and missed on MDCT (all results)
Weight (g)
(range)
Adenoma (25 glands weighed) 1.51 (0.08-6.00)
Correctly localized adenoma (TP results in 20
weighed glands)
1.48 (0.08-4.70)
Hyperplasia (12 glands weighed) 0.4 (0.02-2.00)
Missed hyperplasia (FN results in 9 weighed glands) 0.2 (0.02-0.78)
FN ¼ false negative; MDCT ¼ multidetector computed tomography; TP ¼
true positive.
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emerging technique that uses 4-dimensional (4D) CT revealed
a sensitivity of 70% in localizing parathyroid disease to the
correct quadrant of the neck, with 88% sensitivity for later-
alization [10]. Our 80% sensitivity for localizing parathyroid
adenomas slightly surpasses these sensitivities. We found
only 1 study that used MDCT that revealed a better sensitivity
for precise localization of parathyroid disease. This study
used the novel 4D-CT technique that used differences in
parathyroid gland perfusion characteristics as a surrogate
indicator of function. In this study, Mortenson et al [13]
localized parathyroid disease with a sensitivity of 88%.
Our overall sensitivity of 57% for detection of both
adenoma and hyperplasia was slightly lower than that repor-
ted in the literature. These findings may be due to a number of
factors. First, in the general population, the rate of parathyroid
hyperplasia as an etiology of primary hyperparathyroidism is
approximately 6%-10% [1,2,5], and hyperplastic glands tend
to be smaller and inherently more difficult to detect [9,16]. In
our series, 16% of the patients were affected with parathyroid
hyperplasia, whereas other studies had lower hyperplasia
frequencies, some with as few as 5% [4,8,10,14]. Thus, it is
possible that our lower sensitivity for identifying all hyper-
functioning parathyroid glands was affected by our higher
than average proportion of hyperplastic glands. Second,
because our statistics were calculated on a per-gland rather
than per-patient basis, failure to diagnosis parathyroid
hyperplasia resulted in multiple FN results. For example, in
a patient with 4-gland hyperplastic disease that was not
radiologically detected, 4 FN results were tallied. Whereas in
a patient with a single parathyroid adenoma that was not
radiologically detected, only one FN result was tallied. Thus,
in our study, by virtue of our statistical analysis, each missed
diagnosis of parathyroid hyperplasia gave rise to multiple FN
outcomes, thus decreasing our overall sensitivity and accu-
racy. Third, as a tertiary care centre, our patient referrals
originated from a highly specialized head and neck surgeon.
Almost half of the patients in our study (42%) had prior neck
surgery, including thyroid surgery and neck exploration for
primary hyperparathyroidism, which reflected a complex
patient population with respect to altered neck anatomy,
fibrotic changes, and anomalies in parathyroid number and
position. Fourth, 53% of patients demonstrated nonlocalizing
NM studies, which represents our unique institutional expe-
rience. The overall accuracy of sestamibi is substantially
higher in the literature compared with our series, possibly
a manifestation of our older camera technology, referral bias,
and more complicated disease, which may have made
detection of abnormal glands more difficult by MDCT.
Finally, the aforementioned studies that used 4D-CT had
improved sensitivity in detecting all hyperfunctioning glands
but at the expense of a 4-fold increase in radiation to the
patient. Moreover, 4D-CT is not readily available at all
imaging centres, and there exists a relative lack of experience
and validation [1].
Another study in the literature [14] has used positive
predictive value as a key measure in evaluating the capacityof a preoperative imaging study to guide the surgeon to the
precise location of an abnormal parathyroid gland. Indeed,
positive predictive value by virtue of its statistical equation
serves to assess how often an imaging-predicted abnormal
parathyroid gland will be found in its exact predicted loca-
tion during surgery. An imaging modality that demonstrates
a high positive predictive value assures that surgical inter-
vention will be initiated within the correct neck quadrant
(location) more frequently, thus reaping the benefits of
a minimally invasive approach. In our series, MDCT is
efficacious in correctly predicting both adenoma and
hyperplasia location, with a positive predictive value of 88%.
To compare, Zald et al [14] reveal a positive predictive value
for localization and lateralization of parathyroid adenomas of
69% and 87%, respectively.
No prior study to our knowledge has reported the sensi-
tivity of MDCT in exclusively detecting parathyroid hyper-
plasia. In this series, the sensitivity for diagnosing
hyperplasia was 17%. The challenge of detecting parathyroid
hyperplasia is not unique to CT. In a study by Sugg et al [16],
sestamibi and US detected MGD in only 9% and 26% of
patients, respectively. The poor sensitivity for detection of
MGD is likely the result of the smaller size and weight of the
abnormal hyperplastic glands. In our series, the average
weight of missed hyperplastic glands was 200 mg, with all
missed hyperplastic glands weighing less than 800 mg. This
concept is corroborated in a study by Younes et al [9] in
which 50% of the missed hyperplastic glands weighed less
than 500 mg. A NM study by Nichols et al [17] revealed
significantly lower sensitivity in detecting parathyroid
lesions, with a median weight of 600 mg or less, with
significantly lower per-lesion sensitivity for MGD.
The Cohen k value of this series was 0.42, which corre-
sponds to moderate strength of agreement between the 2
radiologist readers. One of the readers was a radiologist with
particular interest and experience in parathyroid imaging,
whereas the other radiologist had more limited experience.
Therefore, our k value likely reflects a learning curve required
for this type of interpretation. Because MDCT is a reproduc-
ible modality, the range of interpretation and interobserver
agreement plausibly reflects the volume of cases and operator
experience of each radiologist reader. Randall et al [11]
comment from practical experience that there exists
a learning curve for identifying adenomas, particularly when
ectopic. A study by Zald et al [14] that involved 2 readers
revealed a very comparable k value of 0.44.
Although MDCT rivals NM and US in detecting para-
thyroid disease and offers distinct advantages over both
modalities, the examination is certainly not flawless. In our
experience, pitfalls of MDCT for parathyroid localization
include previous thyroid surgery, exophytic thyroid nodules,
goiters, and differentiating normal lymph nodes from para-
thyroid abnormalities. Because MDCT relies on the vascu-
larity of parathyroid glands and their increased enhancement
compared with surrounding structures, glands immediately
adjacent to the thyroid are less readily detected as the thyroid
gland enhances comparably.
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study was performed in a retrospective manner, and, because
all the patients underwent surgical exploration, there was an
obvious selection bias. The sample size of 49 cases was
relatively limited. Although not used as a reference standard,
calcium levels were not recorded for all patients after surgery
to ensure eucalcemia, because some patients no longer
received follow-up at our institution. A single pathologist
reviewed the specimens, but multiple pathologists were
involved in the study. Thus, parathyroid adenoma and
hyperplasia weights were not documented for all removed
glands.
In summary, contrast-enhanced MDCT is a good primary
imaging modality in the setting of primary hyperparathy-
roidism, effectively guiding the surgeon to the location of
adenomatous and hyperplastic glands, with a positive
predictive value of 88%. Most importantly, MDCT generates
precise anatomical information of the neck and upper
mediastinum and characterizes the relationships of abnormal
parathyroid glands to other tissues and vascular structures.
In the future, CT may become the only required modality,
not only for the diagnosis of parathyroid disease in the
setting of primary hyperparathyroidism but also for the
obligatory surgical road-mapping of minimally invasive
surgery. Certainly, additional prospective work is necessary
to prove the ability of CT to diagnose parathyroid disease
independently and in conjunction with other imaging
modalities for the purpose of establishing the most cost-
effective preoperative algorithmic approach. Finally, there
must be close communication between the radiologist and
the surgeon to optimize preoperative imaging strategies and
to maximize the success of minimally invasive surgical
techniques.
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